This is an archived article.

December 10, 2009

UW Medicine’s Institute of Translational Health Sciences presents Breast Cancer Screening – The New Guidelines: Can We Make Sense Out of the Controversy?

UW Health Sciences/UW Medicine

WHO: Alfred O. Berg, M.D., M.P.H., Professor, Family Medicine, Family Medicine Research Section, Former Chairman, United States Preventive Services Task Force


Joann G. Elmore, M.D., M.P.H. (Moderator), Professor of Medicine, Section Head, Division of General Internal Medicine, Harborview Medical Center



Paul Fishman, Ph.D., Associate Investigator, Group Health Research Institute, Affiliate Associate Professor, Health Services


Constance Lehman, M.D., Ph.D., Professor, Radiology, Director of Breast Imaging, Seattle Cancer Care Alliance


Diana L. Miglioretti, Ph.D., Senior Investigator, Group Health Research Institute, Affiliate Associate Professor, Biostatistics


WHAT: An interdisciplinary panel of researchers and providers will discuss the controversy surrounding the new breast cancer screening guidelines. In November, the U.S. Preventive Services Task Force released new guidelines regarding breast cancer screening. The delivery of the guidelines, coupled with intense media attention, has generated confusion among patients, health care professionals and lawmakers. A national debate over how to interpret the guidelines is ongoing.


WHEN: Thursday, December 17, 2009 — 12:00 p.m. to 1:30 p.m.


WHERE: Hogness Auditorium, Warren G. Magnuson Health Sciences Center

University of Washington, 1959 N.E. Pacific Street, Seattle, WA 98195



Note: The Institute of Translational Health Sciences at UW Medicine is a cross-institutional organization that includes UW Medicine, Fred Hutchinson Cancer Research Center, Group Health Research Institute and Seattle Children’s.

# # #